153 related articles for article (PubMed ID: 16837468)
1. Predictions of CCR1 chemokine receptor structure and BX 471 antagonist binding followed by experimental validation.
Vaidehi N; Schlyer S; Trabanino RJ; Floriano WB; Abrol R; Sharma S; Kochanny M; Koovakat S; Dunning L; Liang M; Fox JM; de Mendonça FL; Pease JE; Goddard WA; Horuk R
J Biol Chem; 2006 Sep; 281(37):27613-20. PubMed ID: 16837468
[TBL] [Abstract][Full Text] [Related]
2. Site-directed mutagenesis of CC chemokine receptor 1 reveals the mechanism of action of UCB 35625, a small molecule chemokine receptor antagonist.
de Mendonça FL; da Fonseca PC; Phillips RM; Saldanha JW; Williams TJ; Pease JE
J Biol Chem; 2005 Feb; 280(6):4808-16. PubMed ID: 15548526
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1.
Liang M; Mallari C; Rosser M; Ng HP; May K; Monahan S; Bauman JG; Islam I; Ghannam A; Buckman B; Shaw K; Wei GP; Xu W; Zhao Z; Ho E; Shen J; Oanh H; Subramanyam B; Vergona R; Taub D; Dunning L; Harvey S; Snider RM; Hesselgesser J; Morrissey MM; Perez HD
J Biol Chem; 2000 Jun; 275(25):19000-8. PubMed ID: 10748002
[TBL] [Abstract][Full Text] [Related]
4. Structure function differences in nonpeptide CCR1 antagonists for human and mouse CCR1.
Onuffer J; McCarrick MA; Dunning L; Liang M; Rosser M; Wei GP; Ng H; Horuk R
J Immunol; 2003 Feb; 170(4):1910-6. PubMed ID: 12574358
[TBL] [Abstract][Full Text] [Related]
5. CCR1-specific non-peptide antagonist: efficacy in a rabbit allograft rejection model.
Horuk R; Shurey S; Ng HP; May K; Bauman JG; Islam I; Ghannam A; Buckman B; Wei GP; Xu W; Liang M; Rosser M; Dunning L; Hesselgesser J; Snider RM; Morrissey MM; Perez HD; Green C
Immunol Lett; 2001 Apr; 76(3):193-201. PubMed ID: 11306147
[TBL] [Abstract][Full Text] [Related]
6. Exploring a model of a chemokine receptor/ligand complex in an explicit membrane environment by molecular dynamics simulation: the human CCR1 receptor.
Shahlaei M; Madadkar-Sobhani A; Fassihi A; Saghaie L
J Chem Inf Model; 2011 Oct; 51(10):2717-30. PubMed ID: 21910472
[TBL] [Abstract][Full Text] [Related]
7. Identifying bias in CCR1 antagonists using radiolabelled binding, receptor internalization, β-arrestin translocation and chemotaxis assays.
Gilchrist A; Gauntner TD; Fazzini A; Alley KM; Pyen DS; Ahn J; Ha SJ; Willett A; Sansom SE; Yarfi JL; Bachovchin KA; Mazzoni MR; Merritt JR
Br J Pharmacol; 2014 Nov; 171(22):5127-38. PubMed ID: 24990525
[TBL] [Abstract][Full Text] [Related]
8. The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1alpha and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation.
Pease JE; Wang J; Ponath PD; Murphy PM
J Biol Chem; 1998 Aug; 273(32):19972-6. PubMed ID: 9685332
[TBL] [Abstract][Full Text] [Related]
9. Chemokine receptor CCR1: a new target for progressive kidney disease.
Ninichuk V; Anders HJ
Am J Nephrol; 2005; 25(4):365-72. PubMed ID: 16088077
[TBL] [Abstract][Full Text] [Related]
10. Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model.
Menu E; De Leenheer E; De Raeve H; Coulton L; Imanishi T; Miyashita K; Van Valckenborgh E; Van Riet I; Van Camp B; Horuk R; Croucher P; Vanderkerken K
Clin Exp Metastasis; 2006; 23(5-6):291-300. PubMed ID: 17086356
[TBL] [Abstract][Full Text] [Related]
11. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome.
Vielhauer V; Berning E; Eis V; Kretzler M; Segerer S; Strutz F; Horuk R; Gröne HJ; Schlöndorff D; Anders HJ
Kidney Int; 2004 Dec; 66(6):2264-78. PubMed ID: 15569315
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor.
Hesselgesser J; Ng HP; Liang M; Zheng W; May K; Bauman JG; Monahan S; Islam I; Wei GP; Ghannam A; Taub DD; Rosser M; Snider RM; Morrissey MM; Perez HD; Horuk R
J Biol Chem; 1998 Jun; 273(25):15687-92. PubMed ID: 9624164
[TBL] [Abstract][Full Text] [Related]
13. A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection.
Horuk R; Clayberger C; Krensky AM; Wang Z; Grone HJ; Weber C; Weber KS; Nelson PJ; May K; Rosser M; Dunning L; Liang M; Buckman B; Ghannam A; Ng HP; Islam I; Bauman JG; Wei GP; Monahan S; Xu W; Snider RM; Morrissey MM; Hesselgesser J; Perez HD
J Biol Chem; 2001 Feb; 276(6):4199-204. PubMed ID: 11054419
[TBL] [Abstract][Full Text] [Related]
14. Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle.
Mirzadegan T; Diehl F; Ebi B; Bhakta S; Polsky I; McCarley D; Mulkins M; Weatherhead GS; Lapierre JM; Dankwardt J; Morgans D; Wilhelm R; Jarnagin K
J Biol Chem; 2000 Aug; 275(33):25562-71. PubMed ID: 10770925
[TBL] [Abstract][Full Text] [Related]
15. BX-471 Berlex.
Elices MJ
Curr Opin Investig Drugs; 2002 Jun; 3(6):865-9. PubMed ID: 12137405
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of chemically synthesized derivatives of the human CC chemokine CCL15/HCC-2, a high affinity CCR1 ligand.
Escher SE; Forssmann U; Frimpong-Boateng A; Adermann K; Vakili J; Sticht H; Detheux M
J Pept Res; 2004 Jan; 63(1):36-47. PubMed ID: 14984572
[TBL] [Abstract][Full Text] [Related]
17. Species selectivity of a small molecule antagonist for the CCR1 chemokine receptor.
Liang M; Rosser M; Ng HP; May K; Bauman JG; Islam I; Ghannam A; Kretschmer PJ; Pu H; Dunning L; Snider RM; Morrissey MM; Hesselgesser J; Perez HD; Horuk R
Eur J Pharmacol; 2000 Feb; 389(1):41-9. PubMed ID: 10686294
[TBL] [Abstract][Full Text] [Related]
18. First principles predictions of the structure and function of g-protein-coupled receptors: validation for bovine rhodopsin.
Trabanino RJ; Hall SE; Vaidehi N; Floriano WB; Kam VW; Goddard WA
Biophys J; 2004 Apr; 86(4):1904-21. PubMed ID: 15041637
[TBL] [Abstract][Full Text] [Related]
19. Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease.
Ninichuk V; Gross O; Reichel C; Khandoga A; Pawar RD; Ciubar R; Segerer S; Belemezova E; Radomska E; Luckow B; Perez de Lema G; Murphy PM; Gao JL; Henger A; Kretzler M; Horuk R; Weber M; Krombach F; Schlöndorff D; Anders HJ
J Am Soc Nephrol; 2005 Apr; 16(4):977-85. PubMed ID: 15716328
[TBL] [Abstract][Full Text] [Related]
20. CCR1 chemokine receptor antagonist.
Saeki T; Naya A
Curr Pharm Des; 2003; 9(15):1201-8. PubMed ID: 12769747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
